Innovationeering in 2015: eight and a half forecasts


Innovationeering in 2015: eight and a half forecasts

The future focus of innovation

1. Breakthrough innovation – radically different ways of doing things – will become increasingly sought after.

2. Open Innovation – scouting, identification and support of potential innovations – will become increasingly widespread.

3. The drive for innovation will accelerate in systems, such as the Internet of Things, especially in services, and including public services.

4. And radical thinking will take place around the very pillars of our culture -capitalism and democracy.

The management of innovation

5. Innovation and its management will become increasingly aligned with strategies, and increasingly important.

6. Leaders will increasingly articulate the needs and opportunities for innovation in their particular field; and will induce entrepreneurial talent to work with or for them.

7. Innovation team-building and team working will increasingly become the focus of attention; and teams will become more fluid in their composition (1).

8. Coaching and mentoring will transfer from sport and the arts to business, enterprise, education and healthcare; and will become increasingly expert.

And one from left field

9. Organisations will increasingly look to behavioural economics and psychology for new ways in which to bring about change.

(1) For example, creative groups are led by ‘visionaries’ rather than by ‘co-ordinators’. For more, see ‘Releasing Creativity – how leaders develop creative potential in their teams’ John Whatmore, Kogan Page, 1999, available on Amazon.

John Whatmore December 2014
The Centre for Leadership in Creativity


Building Open Innovation in Bioscience


Building the Stevenage Bioscience community  An Open Innovation brand is developing – nurturing innovation

SBC is a ground-breaking Incubator, located beside a big pharma, designed to enhance time to market – by encouraging contact with the wide variety of sources of help that it musters.

First and foremost we are about changing attitudes and cultures in both academia and industry, from small to large organizations – getting them both to recognize that there is another way of developing and translating research in the life sciences, and early engagement through partnership, collaboration, and even open innovation that might just make a difference in commercialising an opportunity.  We are all striving for a model that enhances time to market in an optimal way for those innovations that tick the faster, better, cheaper boxes, so why not take a different approach?

Open Innovation, as with all innovation approaches, is truly a contact sport – our tenants are actually engaging in early stage collaboration activities of all sizes with little or no money exchanging hands. Activities include regular tenant coffee morning meetings to speak and engage, more formal “SBC Connect” events where one can present to a GSK R&D audience, joint poster sessions, and information sessions about how to access GE’s latest cell technologies (as well as antibody production and analytical platforms) on site.                                                                                                                                                                                                                                                                                                                                                                                                       “Why not talk to Suki from Labstract about access to Chemistry and Biology related platforms in the Community zone? Did you hear we have a FACS Arria on site for flow cytometry analysis?  Do you think we should have a seminar in our series of science seminars around cell therapies? Our tenant meetings are great!  You want to access our Expert’s Panel for discussions around your business plan? You want us to introduce you to Chris at Syncona or Louis at Kurma? You need Barbara Domayne-Hayman, our Entrepreneur in Residence, to help write a grant funding application or advise on your current approach to market? Is Christina Patino (our Business Development Executive) able to find you a technical expert through her University contacts?” Questions from tenants and partners on how to access hi-spec equipment through Labstract, how to reach an expert to provide feedback on a business plan, or how to get an introduction to one of our VC partners are all welcome, [though apparently there are no mentors assigned to tenants.]

Now, precedent has been set that if you build an Incubator and Accelerator next to one of the biggest Pharma in the world, not only do tenants come, but the quality and diversity is truly impressive, as well.  From very early stage all the way up to Phase 1 clinical development, since opening our doors in February 2012 we have created an impressive array of IP and research-based opportunities.

Precis of article by Martino Picardo, CEO, Stevenage Bioscience Catalyst November 2013